Articles:

Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments

P Pantazis
Clin Cancer Res 1995 1: 1235 [Abstract] [PDF]  

Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions

H Tahara, H Kuniyasu, H Yokozaki, W Yasui, JW Shay, T Ide, and E Tahara
Clin Cancer Res 1995 1: 1245 [Abstract] [PDF]  

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin

W Debinski, NI Obiri, SK Powers, I Pastan, and RK Puri
Clin Cancer Res 1995 1: 1253 [Abstract] [PDF]  

Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6

D Brooks, C Taylor, B Dos Santos, H Linden, A Houghton, TT Hecht, S Kornfeld, and R Taetle
Clin Cancer Res 1995 1: 1259 [Abstract] [PDF]  

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer

L Vahdat, G Raptis, D Fennelly, N Hamilton, L Reich, A Tiersten, M Harrison, C Hudis, M Moore, and TJ Yao
Clin Cancer Res 1995 1: 1267 [Abstract] [PDF]  

Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion

I Rafi, GA Taylor, JA Calvete, AV Boddy, K Balmanno, N Bailey, M Lind, AH Calvert, S Webber, and RC Jackson
Clin Cancer Res 1995 1: 1275 [Abstract] [PDF]  

Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen

KA Foon, AR Oseroff, L Vaickus, SJ Greenberg, D Russell, Z Bernstein, S Pincus, H Kohler, BK Seon, and E Tahaoglu
Clin Cancer Res 1995 1: 1285 [Abstract] [PDF]  

p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy

JJ Bauer, IA Sesterhenn, KF Mostofi, DG McLeod, S Srivastava, and JW Moul
Clin Cancer Res 1995 1: 1295 [Abstract] [PDF]  

Expression of the multidrug resistance-associated protein (MRP) gene in human cancers

K Nooter, AM Westerman, MJ Flens, GJ Zaman, RJ Scheper, KE van Wingerden, H Burger, R Oostrum, T Boersma, and P Sonneveld
Clin Cancer Res 1995 1: 1301 [Abstract] [PDF]  

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model

NI Goldstein, M Prewett, K Zuklys, P Rockwell, and J Mendelsohn
Clin Cancer Res 1995 1: 1311 [Abstract] [PDF]  

Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64)

J Chen, JH Zhou, and ED Ball
Clin Cancer Res 1995 1: 1319 [Abstract] [PDF]  

Alterations in T cell receptor and signal transduction molecules in melanoma patients

AH Zea, BD Curti, DL Longo, WG Alvord, SL Strobl, H Mizoguchi, SP Creekmore, JJ O'Shea, GC Powers, and WJ Urba
Clin Cancer Res 1995 1: 1327 [Abstract] [PDF]  

In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells

A Guglielmi, C Aschele, A Mori, C Baldo, P Russo, D Debernardis, M Valenti, S Bruno, M Taverna, and R Rosso
Clin Cancer Res 1995 1: 1337 [Abstract] [PDF]  

Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples

F Geoffroy, W Dahut, CH Takimoto, and JL Grem
Clin Cancer Res 1995 1: 1345 [Abstract] [PDF]  

Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft

S Tamura, KF Ouchi, K Mori, M Endo, T Matsumoto, H Eda, Y Tanaka, H Ishitsuka, H Tokita, and K Yamaguchi
Clin Cancer Res 1995 1: 1353 [Abstract] [PDF]  

Retroviral transfer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxicity

LC Harris, UK Marathi, CC Edwards, PJ Houghton, DK Srivastava, EF Vanin, BP Sorrentino, and TP Brent
Clin Cancer Res 1995 1: 1359 [Abstract] [PDF]  

Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity

Y Zou, W Priebe, LC Stephens, and R Perez-Soler
Clin Cancer Res 1995 1: 1369 [Abstract] [PDF]  

Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy

G Gasparini, P Bevilacqua, E Bonoldi, A Testolin, A Galassi, P Verderio, P Boracchi, RB Guglielmi, and F Pezzella
Clin Cancer Res 1995 1: 1375 [Abstract] [PDF]  

Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer

A Latil, O Cussenot, G Fournier, JC Baron, and R Lidereau
Clin Cancer Res 1995 1: 1385 [Abstract] [PDF]  

Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide

CE Herzog, LA Zwelling, A McWatters, and ES Kleinerman
Clin Cancer Res 1995 1: 1391 [Abstract] [PDF]  

Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein

V Ponnathpur, AM Ibrado, JC Reed, S Ray, Y Huang, S Self, G Bullock, A Nawabi, and K Bhalla
Clin Cancer Res 1995 1: 1399 [Abstract] [PDF]  

Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer

ER Sauter, JA Ridge, S Litwin, and CJ Langer
Clin Cancer Res 1995 1: 1407 [Abstract] [PDF]  

Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression

H Friess, Y Yamanaka, MS Kobrin, DA Do, MW Buchler, and M Korc
Clin Cancer Res 1995 1: 1413 [Abstract] [PDF]  

Elevated levels of 2',5'-linked oligoadenylate-dependent ribonuclease L occur as an early event in colorectal tumorigenesis

L Wang, A Zhou, S Vasavada, B Dong, H Nie, JM Church, BR Williams, S Banerjee, and RH Silverman
Clin Cancer Res 1995 1: 1421 [Abstract] [PDF]  

Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation

E Surmacz and JL Burgaud
Clin Cancer Res 1995 1: 1429 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.